SCHEMBL7862988

SCHEMBL7862988

C=C(CC)C(=O)C(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL182647 0.84 TDP1 (0.41)
SCHEMBL17865 0.81
SCHEMBL156659 0.81 FFAR3 (0.47)
1,1-Dichloroethene SCHEMBL10628226 0.80 FFAR3 (0.40)
Ammonia Solution, Strong SCHEMBL93844 0.79
Methyl Alcohol SCHEMBL8845851 0.79
Ethylene SCHEMBL57344 0.79
Oxalic Acid SCHEMBL7521918 0.79 FFAR3 (0.44)
Hydrochloric Acid SCHEMBL7789541 0.79
Methane SCHEMBL3265965 0.79

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0788362-B1 PHOSPONOCARBOXYLATE COMPOUNDS FOR TREATING ABNORMAL CALCIUM AND PHOSPHATE METABOLISM PROCTER & GAMBLE PHARMA (US) 2001-07-25 EP disclosed
US-5760021-A TREATING OR PREVENTING METABOLIC BONE DISORDERS THE PROCTER & GAMBLE COMPANY (US) 1998-06-02 US disclosed
EP-0788362-A1 PHOSPONOCARBOXYLATE COMPOUNDS FOR TREATING ABNORMAL CALCIUM AND PHOSPHATE METABOLISM PROCTER &amp; GAMBLE PHARMACEUTICALS, INC. (US) 1997-08-13 EP disclosed
WO-1993024131-A1 PHOSPONOCARBOXYLATE COMPOUNDS FOR TREATING ABNORMAL CALCIUM AND PHOSPHATE METABOLISM PROCTER & GAMBLE PHARMACEUTICALS, INC. (US) 1993-12-09 WO disclosed